Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer.

ABSTRACT:

Background

Digital patient monitoring (DPM) tools can facilitate early symptom management for patients with cancer through systematic symptom reporting; however, low adherence can be a challenge. We assessed patient/healthcare professional (HCP) use of DPM in routine clinical practice.

Materials and methods

Patients with locally advanced/metastatic lung cancer or HER2-positive breast cancer received locally approved/reimbursed drugs alongside DPM, with elements tailored by F. Hoffmann-La Roche Ltd, on the Kaiku Health DPM platform. Patient access to the DPM tool was through their own devices (eg, laptops, PCs, smartphones, or tablets), via either a browser or an app on Apple iOS or Android devices. Coprimary endpoints were patient DPM tool adoption (positive threshold: 60%)

SUBMITTER: Arriola E 

PROVIDER: S-EPMC10994260 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature